Press Releases

Press Releases

Flex Pharma, Inc., a biotechnology company that is developing innovative and proprietary treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions, today announced that it will present a corporate overview at the following upcoming healthcare investor conferences in November: • The Piper Jaffray 27th Annual Healthcare Conference on…

Press Releases

MEI Pharma, Inc., an oncology company focused on the clinical development of novel therapies for cancer, will host its Annual Meeting of Stockholders at 10:00 a.m. Eastern time on Thursday, December 3, 2015, at the offices of Morgan, Lewis & Bockius LLP, located at 101 Park Avenue, New York, NY…

Press Releases

Nuvo Research Inc., a specialty pharmaceutical company with growing revenues and a diverse portfolio of topical and immunology products, today announced that the Toronto Stock Exchange ("TSX") has conditionally approved the listing of Crescita Therapeutics Inc. ("Crescita").  Crescita would be a newly formed company that would own and operate Nuvo's…

Press Releases

PharmaEngine, Inc. announced that The Lancet has published the manuscript entitled "Nanoliposomal irinotecan with fluorouracil and leucovorin in metastatic pancreatic cancer after prior gemcitabine-based therapy (NAPOLI-1): a global, randomized, open-label phase 3 trial" online in advance of its print issue. The Lancet is one of the most prestigious and best…

Press Releases

Bayer HealthCare Pharmaceuticals announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration seeking approval for LCS-16, an investigational hormonal intrauterine device (IUD) for pregnancy protection for up to five years. The submission is based on data from the Phase III clinical…

Press Releases

Mylan N.V. today confirmed that its subsidiaries Mylan Pharmaceuticals Inc., Mylan Laboratories Limited and Mylan Inc., have been sued by Warner Chilcott (US), LLC, Warner Chilcott Company, LLC and Qualicaps Co. Ltd. in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug…

Press Releases

Zipdrug, the leading on-demand prescription medication delivery company, today announced that it has closed a $2.6 million seed funding round, led by Collaborative Fund.  Zipdrug will be using the proceeds to open new markets, grow its internal team and enhance the platform's capabilities as it scales its efforts to power…

Press Releases

RetroSense Therapeutics, a privately-held, clinical-stage biotechnology company, announced today that Therapeutic Area Partnerships has selected RetroSense lead compound, RST-001, as a “Top Project to Watch: Most Licensable Products” for the third consecutive year. RetroSense recently also won the “Deals of the Year” Research Award from MLive and Ann Arbor News.…

Press Releases

Turing Pharmaceuticals AG, a privately-held biopharmaceutical company focused on developing and commercializing innovative treatments for serious diseases and conditions, today announced a Sponsored Research Agreement with the University of Toledo to discover and develop new treatments for Canavan Disease. TUR-007 is a preclinical drug candidate targeting pathological mechanisms associated with…

Press Releases

Adare Pharmaceuticals, Inc. and the Cincinnati Children’s Hospital Medical Center today announced that they are partnering together on an Innovation Fund, which will focus on optimizing and reformulating medicines to better meet the needs of children. This collaboration leverages the experience of Cincinnati Children’s, a leading pediatric research and clinical…